ASP Isotopes (NASDAQ:ASPI) Shares Up 5.3% – Still a Buy?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) were up 5.3% during mid-day trading on Tuesday . The company traded as high as $7.61 and last traded at $7.6250. Approximately 2,664,660 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 4,306,078 shares. The stock had previously closed at $7.24.

Analyst Ratings Changes

Several analysts have commented on ASPI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday. Loop Capital set a $15.00 target price on ASP Isotopes in a research report on Monday, October 27th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research note on Wednesday, September 17th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.00.

ASP Isotopes Price Performance

The company has a debt-to-equity ratio of 3.53, a current ratio of 14.72 and a quick ratio of 14.56. The firm’s 50 day moving average is $9.56 and its 200 day moving average is $8.78. The firm has a market cap of $620.24 million, a P/E ratio of -5.23 and a beta of 3.28.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 253.04%. The business had revenue of $4.89 million for the quarter, compared to the consensus estimate of $2.25 million. As a group, analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.

Insider Activity at ASP Isotopes

In other news, Director Michael Gorley sold 64,000 shares of the firm’s stock in a transaction on Tuesday, September 30th. The stock was sold at an average price of $9.75, for a total transaction of $624,000.00. Following the completion of the transaction, the director directly owned 81,360 shares in the company, valued at $793,260. This trade represents a 44.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul Elliot Mann sold 81,077 shares of ASP Isotopes stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $8.39, for a total value of $680,236.03. Following the completion of the transaction, the chief executive officer directly owned 8,084,191 shares of the company’s stock, valued at approximately $67,826,362.49. This represents a 0.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 473,699 shares of company stock worth $4,225,902 over the last quarter. 21.40% of the stock is currently owned by company insiders.

Institutional Trading of ASP Isotopes

Institutional investors and hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP bought a new position in shares of ASP Isotopes in the third quarter worth approximately $34,000. Ameritas Investment Partners Inc. increased its position in shares of ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after acquiring an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after acquiring an additional 2,548 shares during the last quarter. Close Asset Management Ltd bought a new position in ASP Isotopes in the 3rd quarter valued at approximately $72,000. Finally, Legal & General Group Plc lifted its position in ASP Isotopes by 30.4% in the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after acquiring an additional 1,953 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.